Cagrilintide 10mg - 10 Vials (KIT)

Strictly for in vitro laboratory research and analytical identification only. Not for human or veterinary use.

Cagrilintide is an experimental weight-loss peptide developed by Novo Nordisk. It is designed to reduce appetite, increase feelings of fullness and help people consume fewer calories.

It works differently from traditional GLP-1 medications such as Ozempic.

Cagrilintide mimics a naturally occurring hormone called amylin, which is released by the pancreas after eating.

It works by:

Suppressing appetite: Helps reduce hunger.

Increasing fullness: Makes you feel satisfied for longer.

Slowing gastric emptying: Slows how quickly food leaves the stomach.

Reducing food intake: May help reduce overall calorie consumption.

Supporting weight loss: Has demonstrated meaningful weight reduction in clinical trials.

Clinical trials have reported:

Nausea

Vomiting

Constipation

Diarrhoea

Abdominal discomfort

Cagrilintide is primarily an appetite-control peptide, not a direct fat-burning peptide.

Cagrilintide is not an approved medicine for general use.